Sean Lee CFA

Stock Analyst at H.C. Wainwright

(2.54)
# 2,967
Out of 5,010 analysts
266
Total ratings
35.2%
Success rate
1.4%
Average return
Main Sectors:

Stocks Rated by Sean Lee CFA

Dogwood Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $12
Current: $1.35
Upside: +788.89%
Akari Therapeutics,
Aug 18, 2026
Reiterated: Buy
Price Target: $27
Current: $9.55
Upside: +182.72%
Corvus Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $27
Current: $11.76
Upside: +129.59%
Cytosorbents
Aug 7, 2026
Reiterated: Hold
Price Target: $0.75
Current: $4.00
Upside: -81.25%
Myomo
Aug 7, 2026
Reiterated: Buy
Price Target: $5
Current: $1.57
Upside: +218.47%
Senseonics Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $10.05
Upside: +39.30%
Alphatec Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $10.37
Upside: +131.44%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $9.75
Upside: +84.62%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $10.82
Upside: +47.87%
Cerenome
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $1.86
Upside: +1,244.09%
Reiterated: Buy
Price Target: $4
Current: $0.1147
Upside: +3,387.36%
Reiterated: Buy
Price Target: $14
Current: $7.92
Upside: +76.77%
Reiterated: Buy
Price Target: €14.00
Current: €2.25
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $1.60
Upside: n/a
Reiterated: Buy
Price Target: $40
Current: $80.00
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a